These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6206332)

  • 1. Comparisons of the inotropic effects of the beta 1-adrenoceptor partial agonists SL 75.177.10 and ICI 118,587 with digoxin on the intact canine heart.
    Pouleur H; Van Mechelen H; Balasim H; Rousseau MF; Charlier AA
    J Cardiovasc Pharmacol; 1984; 6(4):720-6. PubMed ID: 6206332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
    Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H
    Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist.
    Nuttall A; Snow HM
    Br J Pharmacol; 1982 Oct; 77(2):381-8. PubMed ID: 6128041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of a partial agonist of beta 1 adrenergic receptors (ICI 118,587) on left ventricular performance and metabolism in coronary disease].
    Rousseau MF; Pouleur H; Etienne J; Mengeot P; Cheron P
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):76-84. PubMed ID: 6142702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ICI 118,587 on left ventricular function during graded treadmill exercise in conscious dogs.
    Ohyagi A; Sasayama S; Nakamura Y; Lee JD; Kihara Y; Kawai C
    Am J Cardiol; 1984 Nov; 54(8):1108-13. PubMed ID: 6149683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial, coronary, and peripheral effects of xamoterol (ICI 118,587) in open-chest pigs.
    Galiè N; Metalli M; Zannoli R; Binetti G; Branzi A; Magnani B
    Cardiovasc Drugs Ther; 1989 Mar; 3(1):91-7. PubMed ID: 2577281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the beta adrenoceptor subtype(s) mediating the positive inotropic effects of epinine, dopamine, dobutamine, denopamine and xamoterol in isolated human right atrium.
    Deighton NM; Motomura S; Bals S; Zerkowski HR; Brodde OE
    J Pharmacol Exp Ther; 1992 Aug; 262(2):532-8. PubMed ID: 1354251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term xamoterol therapy on the left ventricular mechanical efficiency in patients with ischemic heart disease.
    Pouleur H; van Eyll C; Etienne J; van Mechelen H; Vuylsteke A; Rousseau MF
    Basic Res Cardiol; 1989; 84 Suppl 1():157-62. PubMed ID: 2573338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
    Hattori Y; Sakuma I; Nakao Y; Kanno M
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the beta 1-adrenergic receptor partial agonist xamoterol on left ventricular diastolic function. An evaluation after 1-6 years of oral therapy.
    Pouleur H; Etienne J; Van Mechelen H; Gurné O; Rousseau MF
    Circulation; 1990 Feb; 81(2 Suppl):III87-92. PubMed ID: 1967560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
    Heng MK
    Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xamoterol recruits an inotropic reserve in the acutely failing, reperfused canine myocardium without detrimental effects on its subsequent recovery.
    Schäfer S; Linder C; Heusch G
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):206-13. PubMed ID: 2146513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Illustration of the effects of long-term xamoterol therapy on the time course of left ventricular pressure.
    van Mechelen H; Ries A; Pouleur H; Rousseau MF
    Eur Heart J; 1990 Apr; 11 Suppl A():67-9. PubMed ID: 1971598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celiprolol: a positive inotropic beta-adrenoceptor blocking agent in conscious dogs.
    Nganele DM; DeLeonardis VM; Hintze TH
    Br J Pharmacol; 1988 Mar; 93(3):501-8. PubMed ID: 2897217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
    Böhm M; Mittmann C; Schwinger RH; Erdmann E
    Am Heart J; 1990 Dec; 120(6 Pt 1):1381-92. PubMed ID: 1978979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic and hemodynamic influences on the rate of isovolumic left ventricular relaxation in the normal conscious dog.
    Karliner JS; LeWinter MM; Mahler F; Engler R; O'Rourke RA
    J Clin Invest; 1977 Sep; 60(3):511-21. PubMed ID: 893662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitation of calcium blocking and membrane effects by intrinsic sympathomimetic activity.
    Smith HJ; Halliday SE; Briscoe MG; Snow HM
    Cardiovasc Res; 1984 Jan; 18(1):30-6. PubMed ID: 6141007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the force-frequency effect on myocardial contractility by adrenergic stimulation in conscious dogs.
    Kambayashi M; Miura T; Oh BH; Rockman HA; Murata K; Ross J
    Circulation; 1992 Aug; 86(2):572-80. PubMed ID: 1353420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of the macrolide antibiotic tilmicosin, administered alone and in combination with propranolol or dobutamine, in conscious unrestrained dogs.
    Main BW; Means JR; Rinkema LE; Smith WC; Sarazan RD
    J Vet Pharmacol Ther; 1996 Jun; 19(3):225-32. PubMed ID: 8803881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.